2025 Controlled Substances and Beyond: The Pain Puzzle, A Comprehensive Review_HOLDER

Save the Date

2025 Controlled Substances and Beyond: The Pain Puzzle, A Comprehensive Review

Friday, May 30, 2025

The Center for Advanced Practice is proud to offer an advanced practice program geared toward prescribing providers that focuses on the principles of pharmacology in relation to Schedule II-IV controlled substances.

This course meets the one-time 8-hour MATE Act training requirement for all DEA-registered practitioners!

If you like to be notified when registration opens, click here.

This program is not yet approved for CME credit. Conference organizers plan to apply for 8.00 AAPA Category 1 CME credits from the AAPA Review Panel. The total number of approved credits is yet to be determined.

Mitigation of Relevant Financial Relationships

Stanford Health Care (SHC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.